Abstract
Bone morphogenetic proteins (BMPs), members of the transforming growth factor Β (TGF-Β) superfamily, are multifunctional secreted growth factors that are essential for coordinating complex developmental processes. Recent advances using genetic and molecular approaches have recognized a previously underappreciated angiogenic role for BMP signaling during vascular development and vascular disease. Compelling evidence includes the discovery of mutations in BMP signaling components that have been found in patients with human hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH). A comprehensive review of in vivo and in vitro studies has revealed that the angiogenic response to BMP signaling is context and ligand dependent. This review provides details on these studies as the field moves towards BMP-mediated therapeutic intervention of human vascular diseases. Keywords: Bone Morphogenetic Protein, BMP signaling, angiogenesis, vascular development, HHT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
